Selling Your Medical Practice to an MSO: Compare the Offer

Key Takeaways

• Compare an MSO offer with a conventional physician-to-physician sale, not just with another MSO offer.
• Separate cash paid at closing from rollover equity, earnouts, and other value that may never become liquid.
• Evaluate purchase price, post-sale compensation, workload, and transition length as one economic package.
• In California, physician-control rules reserve specified decisions to physicians, and 2026 restrictions apply to specified control by private equity groups and hedge funds over physician practices.
• Use different advisors for different questions: commercial structure and value, your legal terms, and tax consequences.

When you’re selling your medical practice to an MSO, the hardest question is rarely whether the headline number sounds large. The harder question is what that number actually includes and how it compares with a more conventional sale to another physician.

A management services organization, or MSO, can provide administrative services and participate in a corporate transaction structure around your medical practice. The transaction may combine cash, rollover equity (a portion of your sale value reinvested into or retained as ownership in the post-closing entity), an earnout (a payment tied to future performance), future compensation, and a continuing work commitment. Each component carries a different level of certainty.

Corporate employment isn’t a fringe issue. A 2026 corporate-employment report found that corporate entities employed 22.3% of U.S. physicians as of January 1, 2026. For you as a physician owner, however, the market trend matters less than whether the proposed structure works for your practice, your financial goals, and your retirement or career plans.

Why Is Selling Your Medical Practice to an MSO Hard to Compare?

It’s hard to compare because an MSO offer may combine several forms of value and several future obligations, while a physician-to-physician sale is often easier to understand.

You may see one large number at the top of an MSO proposal. That number may include:

• cash paid at closing;
• rollover equity in the MSO or another entity;
• an earnout tied to future performance;
• post-sale physician compensation;
• a required employment or clinical-services term; and
• restrictions on competition, termination, or future practice activity.

Those items aren’t economically equivalent. Cash paid at closing is different from private equity that may not be redeemable for years. Purchase proceeds are different from compensation you’ll earn by continuing to work. An earnout is different from an unconditional payment.

In my experience, physician owners often need help comparing the entire MSO structure with what would be more normal in a sale to another physician. Until you separate the pieces, two offers with the same headline value may not be close to equal.

What Is an MSO, and How Does the Structure Work?

An MSO is an entity that provides nonclinical management and administrative services to your medical practice. The exact services, assets, fees, contracts, and ownership arrangements vary.

In one transaction, an MSO may provide billing, staffing support, technology, facilities, or payer-contract administration. In another, the arrangement may be narrower. The investor structures used by corporate buyers also differ in their business models, culture, ownership, and leadership.

Under one common structure, your physician-owned practice pays the MSO a management fee, often a percentage of collections. The MSO may employ nonclinical staff, own certain nonclinical assets, and lease the office to your practice. The American Medical Association’s (AMA) contract guidance recommends examining the ownership, services, compensation, and control terms in the actual agreement.

You shouldn’t automatically treat the MSO as synonymous with the buyer or investor. A private equity group, another corporate investor, an MSO, and a physician-owned professional entity may each have a different role in the transaction.

The management-services agreement isn’t a universal compliance recipe. You have to evaluate a percentage-based fee, asset lease, staffing arrangement, or long-term contract in context. You should understand who owns what, who receives each payment, which obligations continue after closing, and which decisions remain with physicians.

Can an MSO Own a Medical Practice?

The answer depends on state law and the actual transaction structure. Corporate practice of medicine (CPOM) laws address whether and how an unlicensed entity may own or control a medical practice. In California, Medical Board guidance explains that unlicensed entities may not control a medical practice and that physicians must retain ultimate control over specified clinical and practice decisions.

The Medical Board of California identifies reserved decisions that can’t be delegated to an unlicensed entity. These include clinical decisions as well as specified decisions involving coding and billing, medical records, clinical personnel, and parameters for payer contracts.

California also added 2026 restrictions addressing specified control by private equity groups and hedge funds over physician practices. You shouldn’t read the law as a ban on every MSO arrangement. It does reinforce the need to distinguish legitimate administrative services from control that the law reserves to licensed professionals.

The California Attorney General’s June 2026 settlement with Carbon Health, which was announced as subject to court approval, resolved allegations about that company’s structure and conduct. It doesn’t establish that every MSO arrangement is unlawful. It shows why you need to review the contracts and actual allocation of control.

The buyer ordinarily presents the proposed compliance structure, but that doesn’t replace review by your qualified healthcare counsel. Rather than assuming the buyer’s compliance work protects you, ask your counsel to focus on the agreements you will sign and any issue that could expose you, restrict your rights, or affect the value or liquidity of your rollover equity.

How Does Selling Your Medical Practice to an MSO Compare With a Physician Sale?

An MSO sale often offers more structural complexity and possible future upside, while a physician-to-physician sale may offer a simpler path to a defined handoff. Neither structure is automatically better.

These are patterns, not rules. A physician sale can include financing risk, a long transition, or a restrictive covenant. An MSO transaction can be relatively straightforward. The purpose of the comparison is to identify where the risk sits and what you’ll need to keep doing to receive the stated value.

The AMA’s guidance on contract terms recommends examining ownership, governance, compensation, conflicts, exit provisions, and clinical autonomy. Those questions apply directly when you’re asked to exchange a simpler ownership position for a more complicated set of contracts.

How Should You Value Cash, Rollover Equity, and Earnouts?

For transaction-comparison purposes, separate each component by certainty, liquidity, control, and risk rather than adding private rollover equity to cash dollar for dollar. This is a general decision framework, not investment advice. A qualified investment advisor or securities attorney should assess the specific equity terms and risks.

My default benchmark is to seek at least fair market value in cash, supported by an independent valuation of your practice, and to treat rollover equity as potential upside rather than cash. Rollover equity may deserve meaningful risk-adjusted value when the MSO is established and sufficiently vetted, you can evaluate its performance, debt, and ownership structure, you understand the equity rights and dilution risks, and there’s a credible path to liquidity. Even then, you should value it differently from cash.

The U.S. Securities and Exchange Commission’s (SEC) discussion of private-placement risks highlights several relevant concerns: private securities may be highly illiquid, disclosure can be limited, resale can be restricted, and a total loss is possible. The exact securities rules depend on the offering, but the practical lesson is simple. Equity that you can’t sell or redeem when you need the money isn’t the same as cash at closing.

Before assigning meaningful value to rollover equity, ask:

1. What class of equity will I receive?
2. How was its current value determined?
3. What debt and other claims sit ahead of my equity?
4. Can new financing or additional equity dilute my interest?
5. What voting, information, and governance rights will I have?
6. When may I transfer or redeem the equity, and who controls that decision?
7. What must happen before I can realistically convert the equity to cash?
8. What happens to my equity if my employment ends or the relationship deteriorates?

An earnout requires a similar analysis. Identify the performance measure, who controls it after closing, how it will be calculated, what information you’ll receive, and what happens if your practice is reorganized or combined with another operation.

The right comparison isn’t the best possible outcome. It’s the range of reasonable outcomes, including one in which the equity remains illiquid or loses most of its value.

How Do Compensation and Transition Terms Affect the Offer?

Post-sale compensation, purchase value, and transition obligations are parts of one economic package. Higher ongoing physician compensation generally leaves less earnings available to the buyer and may support a lower purchase value.

This doesn’t mean you should accept low compensation to increase the headline price. It means you should compare the two together. A high purchase price can become less attractive if it requires years of below-market compensation, an unwanted schedule, aggressive productivity expectations, or a difficult termination provision.

MSO transactions also depend on provider continuity. If another physician is ready to provide care, your transition may be shorter. If the buyer still needs to recruit a replacement, you may be expected to continue providing clinical services while that search is underway.

The investment model described by the AMA can include standardized management systems, infrastructure commitments, and changes in physician ownership. You should therefore understand both the economic terms and how your post-closing practice will actually operate.

Ask these questions before treating compensation as an additional benefit:

• How many years am I required to stay?
• What schedule, call coverage, and productivity level are expected?
• How is compensation calculated, and who may change the formula?
• What happens if the buyer doesn’t recruit a replacement on schedule?
• Can either side terminate the arrangement, and what happens to unpaid consideration or rollover equity?
• Which administrative decisions change after closing, and which decisions remain under physician control?

Two Offers With the Same Headline Value

Consider two hypothetical proposals for your practice. The figures are deliberately omitted because this is a decision framework, not a statement about typical pricing.

Offer A: Physician-to-physician sale

• Most of your purchase value is defined at closing.
• The buyer personally plans to take over patient care.
• You have a defined transition and then exit.
• You may still face financing, collection, or seller-note risk, but the ownership handoff is easier to see.

Offer B: MSO transaction

• Less of your stated value is paid in cash at closing.
• You receive rollover equity and may have an earnout.
• You must continue practicing for several years under a compensation formula.
• The timing and value of your equity depend on the platform’s future performance and a later opportunity to convert it to cash.

Offer B could ultimately produce more value for you. It could also produce less if the equity underperforms, can’t be redeemed, or the working relationship becomes burdensome. Offer A may provide less upside but more certainty and a cleaner exit.

Your decision should turn on what you receive, what you risk, and what you must continue doing. The headline number is only the beginning.

The Advisors to Bring in Before a Letter of Intent

An MSO offer combines valuation, transaction, legal, investment, and tax questions. No single advisor should pretend to cover all of them.

My role can include evaluating fair market value and the commercial structure of your offer. That means separating cash from contingent value, comparing the MSO proposal with a conventional sale, evaluating how compensation and transition affect the economics, and considering whether a broader buyer search would create better options for you.

A qualified healthcare attorney should review the legal documents and risks that affect you. Depending on the structure, this may include the purchase agreement, employment or clinical-services agreement, restrictive covenants, control and governance rights, rollover-equity documents, termination provisions, indemnification, and enforceability. You don’t necessarily need to audit the buyer’s entire corporate practice of medicine system, but you shouldn’t assume the buyer’s compliance work protects your rights.

The AMA recommends obtaining external legal, accounting, and business advice for corporate transactions. A certified public accountant (CPA) or tax advisor should review allocation and after-tax consequences, and a qualified investment advisor or securities attorney should assess material rollover-equity risks. The asset allocation in a business sale can affect how different parts of your transaction are treated for tax purposes.

Before signing a letter of intent, make sure your team can answer:

• How much will I receive in cash at closing?
• Which payments are contingent, and who controls whether I earn them?
• What rights, restrictions, and liquidity terms attach to my rollover equity?
• How do compensation and required work affect my total economics?
• What happens if I, the buyer, or the replacement physician don’t perform as expected?
• Which terms require legal or tax advice before I accept them?

Choose the Structure, Not Just the Number

Selling your medical practice to an MSO can produce a good outcome when the structure fits your financial goals, desired workload, tolerance for investment risk, and preferred transition. It can also disappoint when you treat uncertain equity or future compensation as if it were cash you’ve already received.

If you already have an MSO proposal, an independent valuation or a scoped offer review can help you understand the cash, contingent value, compensation, and continuing obligations in the proposal. If you want representation, negotiation, or a broader buyer search, my California-based, California-licensed brokerage representation can include negotiating with the existing MSO or comparing other qualified buyers.

A confidential conversation is the place to determine which path fits your situation before the structure becomes difficult to change.